Dr. Aditya Bansal

Assistant Professor, VitreoRetinal & Ocular Oncology Services, University of Kentucky. Email: dr.ad.bansal@gmail.com

2 articles

Dr. Aditya Bansal is a committed ophthalmologist with a deep passion for Vitreoretinal disorders and Intraocular Oncology. Currently holding the position of Assistant Professor at the University of Kentucky. His dedication is evident through over 35 peer-reviewed publications, numerous presentations at scientific meetings, and active involvement in continuing professional development, all aimed at advancing the understanding and treatment of retinal disorders. Recognized widely for his research, Dr. Bansal serves as a reviewer for prestigious journals including the British Journal of Ophthalmology, Ophthalmology Retina, RETINA Journal, and the American Journal of Ophthalmology.

  1. Articles 26 Feb 2024 16 min read

    Current Trends and Techniques in Pneumatic Retinopexy

    Introduction Over the past few decades, the approach to treating primary rhegmatogenous retinal detachment (RRD) has undergone significant changes. Initially, scleral buckle (SB) was the standard method, followed by the occasional use of pneumatic retinopexy (PnR), and more recently, pars plana vitrectomy (PPV). This shift has primarily been driven by technological advancements rather than considerations of post-operative functional outcomes or the effectiveness of retinal reattachment.1 However, there is now a growing interest in ensuring both the integrity of reattachment and the resulting functional outcomes, spurred by the availability of multimodal imaging. The goal is not only to increase the success rate of retinal reattachment but also to optimize the reattachment process for the best possible functional results. One challenge observed with PPV is post-operative retinal displacement, also known as a low-integrity retinal attachment (LIRA)2–4. This displacement occurs due to the

  2. Articles 1 Apr 2021 14 min read

    Coats Disease

    Introduction History In 1908 George Coats1 original description of the disease was based primarily on histopathologic examination of enucleated eyes and identified retinal vascular aneurysms, arteriovenous malformations, intra- and subretinal hemorrhages, and exudates. Coats categorized eyes with these characteristic morphologic findings into three groups: Group I demonstrated massive subretinal exudate alone, group II consisted of eyes with massive subretinal exudate, intra and subretinal hemorrhage, and retinal vascular dilatations, and group III included eyes with subretinal exudate and retinal arteriovenous malformations. Von Hippel2 later identified group III as a separate entity, angiomatosis retinae, which led to the exclusion of this group from the spectrum of Coats disease. In 1912, Theodor Leber3 described a disorder with similar retinal vascular abnormalities to Coats disease, but without massive subretinal exudate, hemorrhage, and serous retinal detachment. This became know